These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20478113)

  • 1. Association of resistance to activated protein with the presence of Leiden and Cambridge Factor V mutations in Mexican patients with primary thrombophilia.
    Zavala Hernández C; Hernández Zamora E; Martínez Murillo C; Arenas Sordo Mde L; González Orozco AE; Reyes Maldonado E
    Cir Cir; 2010; 78(2):127-32. PubMed ID: 20478113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients.
    Ruiz-Argüelles GJ; Poblete-Naredo I; Reyes-Núñez V; Garcés-Eisele J; López-Martínez B; Gómez-Rangel JD
    Rev Invest Clin; 2004; 56(5):600-4. PubMed ID: 15776863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family.
    Santamaría A; Soria JM; Tirado I; Mateo J; Coll I; Souto JC; Fontcuberta J
    Thromb Haemost; 2005 Jun; 93(6):1193-5. PubMed ID: 15968408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary thrombophilia in México. VI: lack of statistical association among the inherited thrombophilic conditions].
    Ruiz-Argüelles GJ; González-Carrillo ML; Estrada-Gómez R; Valdés-Tapia P; Parra-Ortega I; Porras-Juárez A
    Gac Med Mex; 2007; 143(4):317-22. PubMed ID: 17969840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [APC resistance--most frequent familial thrombophilia].
    Herren S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):499-501. PubMed ID: 10517118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity.
    Santacroce R; Bossone A; Brancaccio V; Fortina P; Margaglione M
    Thromb Haemost; 2000 Jun; 83(6):963-4. PubMed ID: 10896257
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of "APTT vs RVVT" based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation.
    Baig MA
    Indian J Pathol Microbiol; 2020; 63(2):247-250. PubMed ID: 32317524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C resistance and factor V Leiden in Mexico.
    Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis.
    Tosetto A; Castaman G; Cappellari A; Rodeghiero F
    Thromb Haemost; 2000 Nov; 84(5):811-4. PubMed ID: 11127861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [National evaluation of the diagnosis of activated protein C resistance].
    Montiel-Manzano G; de la Peña-Díaz A; Majluf-Cruz A; Cesarman-Maus G; Corona-de la Peña N; Cruz-Cruz D; Gaminio E; Martínez-Murillo C; Mayagoitia T; Miranda-Peralta E; Poblete T; Quintana-Martínez S; Ramírez R; Razo D; Ruiz de Chávez-Ochoa A; Reyes-Núñez VA; Salazar R; Vicencio-Santiago GV; Villa R
    Rev Invest Clin; 2003; 55(3):358-69. PubMed ID: 14515684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.
    Mikovic D; Rakicevic L; Kovac M; Radojkovic D
    Thromb Haemost; 2000 Oct; 84(4):723-4. PubMed ID: 11057877
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia.
    Bôžiková A; Gabriková D; Sovičová A; Behulová R; Mačeková S; Boroňová I; Petrejčíková E; Soták M; Bernasovská J; Bernasovský I
    J Thromb Thrombolysis; 2012 Oct; 34(3):406-9. PubMed ID: 22562116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of activated protein C resistance(APC-R) and FV Leiden in healthy blood donors and patients with thrombosis].
    Hong M; Wei W; Song S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):455-7. PubMed ID: 11189481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation.
    Brugge JM; Simioni P; Bernardi F; Tormene D; Lunghi B; Tans G; Pagnan A; Rosing J; Castoldi E
    J Thromb Haemost; 2005 Dec; 3(12):2695-702. PubMed ID: 16359508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The factor V (FV) gene ASP79HIS polymorphism modulates FV plasma levels and affects the activated protein C resistance phenotype in presence of the FV Leiden mutation.
    Bossone A; Cappucci F; D'Andrea G; Brancaccio V; Cibelli G; Iannaccone L; Grandone E; Margaglione M
    Haematologica; 2003 Mar; 88(3):286-9. PubMed ID: 12651267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.